Verify Diagnostics announced that Health Canada has authorized the Assure Tech Ecotest COVID-19 serological rapid test to be used at the point-of-care (POC) for the purpose of screening for SARS-CoV-2 antibodies.
Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients...
The Phase IIb ASSURE clinical trial evaluating RVX 208, from Resverlogix, in high-risk cardiovascular patients with low high-density lipoprotein (HDL)...
Hepion Pharmaceuticals, Inc. announced that it has begun wind-down activities in its ASCEND-NASH trial, while continuing to explore strategic alternatives, as previously announced in December 2023.